NCT01204398View on ClinicalTrials.gov

Telmisartan+Amlodipine Fixed Dose Combination in Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

July 31, 2011

Conditions
Hypertension
Interventions
DRUG

telmisartan+amlodipine fixed dose combination

after 2 weeks placebo wash-out, patients will be administered Telmisartan 80mg/Amlodipine 5mg for 8 weeks.

Trial Locations (1)

Unknown

1235.31.86001 Boehringer Ingelheim Investigational Site, Shanghai

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY